Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters








Database
Language
Publication year range
1.
Brain Res ; 1646: 12-24, 2016 09 01.
Article in English | MEDLINE | ID: mdl-27208489

ABSTRACT

Alzheimer's disease (AD) is a disease of complex etiology, involving multiple risk factors. When these risk factors are presented concomitantly, cognition and brain pathology are more severely compromised than if those risk factors were presented in isolation. Reduced cholinergic tone and elevated amyloid-beta (Aß) load are pathological hallmarks of AD. The present study sought to investigate brain pathology and alterations in learning and memory when these two factors were presented together in rats. Rats received either sham surgeries, cholinergic depletions of the medial septum, intracerebroventricular Aß25-35 injections, or both cholinergic depletion and Aß25-35 injections (Aß+ACh group). The Aß+ACh rats were unimpaired in a striatal dependent visual discrimination task, but had impaired acquisition in the standard version of the Morris water task. However, these rats displayed normal Morris water task retention and no impairment in acquisition of a novel platform location during a single massed training session. Aß+ACh rats did not have exacerbated brain pathology as indicated by activated astroglia, activated microglia, or accumulation of Aß. These data suggest that cholinergic depletions and Aß injections elicit subtle cognitive deficits when behavioural testing is conducted shortly after the presentation of these factors. These factors might have altered hippocampal synaptic plasticity and thus resemble early AD pathology.


Subject(s)
Acetylcholine/physiology , Alzheimer Disease/physiopathology , Alzheimer Disease/psychology , Amyloid beta-Peptides/metabolism , Learning , Memory , Peptide Fragments/metabolism , Alzheimer Disease/chemically induced , Alzheimer Disease/metabolism , Amyloid beta-Peptides/administration & dosage , Animals , Antibodies, Monoclonal/administration & dosage , Astrocytes/drug effects , Astrocytes/metabolism , Brain/drug effects , Brain/metabolism , Choline O-Acetyltransferase/metabolism , Cholinergic Agents/administration & dosage , Cholinergic Neurons/drug effects , Cholinergic Neurons/metabolism , Cognition/drug effects , Discrimination, Psychological/drug effects , Disease Models, Animal , Learning/drug effects , Male , Maze Learning/drug effects , Memory/drug effects , Microglia/drug effects , Microglia/metabolism , Peptide Fragments/administration & dosage , Rats , Rats, Long-Evans , Ribosome Inactivating Proteins, Type 1/administration & dosage , Saporins , Septal Nuclei/drug effects , Septal Nuclei/metabolism
2.
Neuroscience ; 272: 65-75, 2014 Jul 11.
Article in English | MEDLINE | ID: mdl-24814724

ABSTRACT

Rewiring the injured corticospinal tract (CST) by promoting connections between CST axons and spared neurons is a strategy being explored experimentally to achieve improved recovery of motor function after spinal cord injury (SCI). Reliable interventions to promote and direct growth of collaterals from injured CST axons are in high demand to promote functionally relevant detour pathways. A promising tool is neurotrophin-3 (NT-3), which has shown growth-stimulating and chemo-attractive effects for spared CST axons caudal to a CST lesion. Yet, efforts to promote growth of injured CST axons rostral to a SCI with NT-3 have been less successful to date. Evidence indicates that immune activation in the local growth environment, either intrinsic or induced by the endotoxin lipopolysaccharide (LPS), can play a decisive role in the CST's responsiveness to NT-3. Here, we test the potential of NT-3 as a tool to enhance and direct collateral growth from the injured CST rostral to a SCI (1) using long-term expression of NT-3 by adeno-associated viral vectors, (2) with and without stimulating the immune system with LPS. Our results indicate that inducing a growth response from injured CST axons into a region of vector-mediated NT-3 expression is possible in the environment of the spinal cord rostral to a SCI, but seems dependent on the distance between the responding axon and the source of NT-3. Our findings also suggest that injured CST axons do not increase their growth response to NT-3 after immune activation with LPS in this environment. In conclusion, this is to our knowledge the first demonstration that NT-3 can be effective at promoting growth of injured CST collaterals far rostral to a SCI. Making NT-3 available in close proximity to CST target axons may be the key to success when using NT-3 to rewire the injured CST in future investigations.


Subject(s)
Axons/metabolism , Nerve Regeneration/physiology , Neurotrophin 3/metabolism , Pyramidal Tracts/metabolism , Spinal Cord Injuries/physiopathology , Spinal Cord/metabolism , Animals , Female , Neuronal Plasticity/physiology , Neurons/metabolism , Pyramidal Tracts/physiopathology , Rats, Inbred Lew , Recovery of Function/drug effects , Spinal Cord Injuries/metabolism
3.
Exp Neurol ; 247: 241-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23684634

ABSTRACT

Restoring voluntary fine motor control of the arm and hand is one of the main goals following cervical spinal cord injury (SCI). Although the functional improvement achievable with rehabilitative training in rat models is frequently accompanied by corticospinal tract (CST) plasticity, CST rewiring alone seems insufficient to account for the observed recovery. Recent investigations in animal models of SCI have suggested that the reticulospinal tract (RtST) might contribute to mediating improved motor performance of the forelimb. Here we investigate whether the spared RtST can compensate for the loss of CST input and whether RtST projections rearrange in response to cervical SCI. Animals underwent unilateral ablation of the dorsal CST and rubrospinal tract at spinal level C4, while the ventral RtST projections were spared. At the end of the six-week recovery period, injured animals had made significant improvements in single pellet reaching. This was not accompanied by increased sprouting of the injured CST above the injury compared to uninjured control animals. Injury-induced changes in RtST fiber density within the gray matter, as well as in the number of RtST collaterals entering the gray matter or crossing the cord midline were minor above the injury. However, all analyses directly below the injured spinal level consistently point to a significant decrease of RtST projections. The mechanism and the functional relevance behind this new finding warrant further study. Our results also suggest that mechanisms other than anatomical plasticity, such as plastic changes on a cellular level, might be responsible for the observed spontaneous recovery.


Subject(s)
Neuronal Plasticity/physiology , Pyramidal Tracts/physiopathology , Recovery of Function/physiology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/therapy , Analysis of Variance , Animals , Brain Stem/metabolism , Brain Stem/pathology , Brain-Derived Neurotrophic Factor/biosynthesis , Brain-Derived Neurotrophic Factor/therapeutic use , Cervical Vertebrae , Disease Models, Animal , Female , Forelimb/physiopathology , Functional Laterality , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Nerve Regeneration , Neuronal Plasticity/drug effects , Neurotrophin 3/biosynthesis , Neurotrophin 3/therapeutic use , Psychomotor Performance , Pyramidal Tracts/pathology , Rats , Rats, Inbred Lew , Recovery of Function/drug effects , Spinal Cord Injuries/metabolism , Time Factors , Transduction, Genetic
4.
Exp Neurol ; 247: 605-14, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23470552

ABSTRACT

Modeling spinal cord injury (SCI) in animals is challenging because an appropriate combination of lesion location, lesion severity and behavioral testing is essential to analyze recovery of motor function. For particular tests such as single pellet reaching, the contribution of individual descending tracts to recovery has been investigated using specific tract ablation or graded lesions. However, it has not been established whether single pellet reaching is sufficiently sensitive for assessing the efficacy of treatments for cervical SCI (e.g., one of the currently most successful treatment approaches: rehabilitative training). To address this issue, we trained adult rats in single pellet reaching before and after a cervical (C4) spinal lesion. Animals with lesions of increasing severity were grouped into categories based on damage to anatomical structures such as the corticospinal tract (CST) and the rubrospinal tract (RST), two descending motor tracts that have been implicated in fine motor control of the forelimb. We related lesion extent to spontaneous recovery and plasticity-promoting post injury training and found that reaching performance was not correlated with lesion size or the extent of CST or RST injury. Interestingly, the dorsolateral quadrant (DLQ) lesion category, in which the unilateral dorsal CST and most of the unilateral RST are lesioned, was the only category that showed a clear effect of plasticity-promoting treatment (i.e., training), indicating its usefulness as a lesion model for this testing paradigm. The DLQ lesion likely strikes a balance between tissue sparing and functional impairment and is, therefore, best suited to maximize the potential to observe treatment effects of plasticity-promoting treatments using single pellet reaching. Because of the specific lesion size that is necessary to observe treatment effects, the single pellet skilled reaching task can be considered a stringent behavioral test and therefore may be useful for predicting translational success of potential treatments. However, due to the variability in the success rate, the labor-intensive nature, and the limited usefulness to test functional outcome of a wide range of lesion severities, we are hesitant to continue to use single pellet reaching to assess the effectiveness of currently available treatments for cervical SCI.


Subject(s)
Extrapyramidal Tracts/pathology , Motor Skills/physiology , Pyramidal Tracts/pathology , Recovery of Function/physiology , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology , Analysis of Variance , Animals , Disease Models, Animal , Exercise Therapy/methods , Female , Functional Laterality , Physical Conditioning, Animal/methods , Rats , Rats, Inbred Lew , Spinal Cord Injuries/rehabilitation , Statistics as Topic
5.
Neurosci Lett ; 539: 77-81, 2013 Feb 28.
Article in English | MEDLINE | ID: mdl-23384567

ABSTRACT

Rehabilitative training is an essential component of current therapeutic strategies for spinal cord injured individuals. However, there are still various open questions that need to be answered in order to optimize training strategies. For example, why can animals trained in a single task perform worse compared to untrained animals when tested in untrained tasks. Such results suggest a potential competition among motor tasks over spared neuronal circuitry. Whether training induced competition for neuronal circuitry may also exist between injured and spared circuitries of the ipsi- and contralesional extremity is currently unknown. Here we investigated whether training restricted to the frontlimb ipsilateral to cervical spinal injury (IF) can impact motor performance of the contralesional frontlimb (CF) in a rat model of cervical SCI. We compared CF performance following general motor training of all limbs (horizontal ladder), following specific training of the IF (pellet reaching), as well as following a combination of both training paradigms. Our findings indicate that adding ipsilateral side-specific training to general training can negatively impact performance of the CF, without resulting in any improvement of performance of the IF. In conclusion, our results emphasize that important decisions have to be made when designing rehabilitative training strategies, ideally taking into account more than the primarily affected extremity.


Subject(s)
Forelimb/physiopathology , Physical Conditioning, Animal , Spinal Cord Injuries/rehabilitation , Animals , Cervical Vertebrae , Female , Rats , Rats, Inbred Lew , Spinal Cord Injuries/physiopathology
6.
Behav Brain Res ; 239: 31-42, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23131414

ABSTRACT

Promoting the rewiring of lesioned motor tracts following a spinal cord injury is a promising strategy to restore motor function. For instance, axonal collaterals may connect to spared, lesion-bridging neurons, thereby establishing a detour for descending signals and thus promoting functional recovery. In our rat model of cervical spinal cord injury, we attempted to promote targeted rewiring of the unilaterally injured corticospinal tract (CST) via the spared reticulospinal tract (RtST). To promote new connections between the two tracts in the brainstem, we administered viral vectors producing two neurotrophins. Brain-derived neurotrophic factor (BDNF), a known promotor of collateral growth, was expressed in the motor cortex, and neurotrophin 3 (NT-3), which has chemoattractive properties, was expressed in the reticular formation. Because rehabilitative training has proven to be beneficial in promoting functionally meaningful plasticity following injury, we added training in a skilled reaching task. Different neurotrophin or control treatments with or without training were evaluated. As hypothesized, improvements of motor performance with the injured forelimb following neurotrophin treatment alone were absent or modest compared to untreated controls. In contrast, we found a significant synergistic effect on performance when BDNF treatment was combined with training. The mechanism of this recovery remains unidentified, as histological analyses of CST and RtST collateral projections did not reveal differences among treatment groups. In conclusion, we demonstrate that following a cervical spinal lesion, rehabilitative training is necessary to translate effects of BDNF into functional recovery by mechanisms which are likely independent of collateral sprouting of the CST or RtST into the gray matter.


Subject(s)
Brain-Derived Neurotrophic Factor/therapeutic use , Neurotrophin 3/therapeutic use , Pyramidal Tracts/physiology , Spinal Cord Injuries/rehabilitation , Spinal Cord Injuries/therapy , Adenoviridae , Animals , Brain-Derived Neurotrophic Factor/administration & dosage , Cells, Cultured , Cervical Vertebrae , Disease Models, Animal , Female , Gene Expression/genetics , Genetic Vectors/administration & dosage , Motor Skills/physiology , Nerve Regeneration/genetics , Nerve Regeneration/physiology , Neurotrophin 3/administration & dosage , Rats , Rats, Inbred Lew , Recovery of Function/genetics
7.
Exp Neurol ; 238(2): 254-64, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22982152

ABSTRACT

Brain-derived neurotrophic factor (BDNF) has been identified as a potent promoter of neurite growth, a finding that has led to an ongoing exploration of this neurotrophin as a potential treatment for spinal cord injury. BDNF's many effects in the nervous system make it an excellent candidate for neuroprotective strategies as well as for promoting axonal regeneration, plasticity and re-myelination. In addition, neuronal activity and physical exercise can modulate the expression of BDNF, suggesting that non-invasive means to increase BDNF levels might exist. Nonetheless, depending on the location, amount and duration of BDNF delivery, this potent neurotrophin can also have adverse effects, such as modulation of nociceptive pathways or contribution to spasticity. Taken together, the benefits and possible risks require careful assessment when considering this multifaceted neurotrophin as a treatment option for spinal cord injury.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Brain-Derived Neurotrophic Factor/therapeutic use , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/metabolism , Animals , Brain-Derived Neurotrophic Factor/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Humans , Neurons/drug effects , Neurons/metabolism , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Spinal Cord Injuries/pathology
SELECTION OF CITATIONS
SEARCH DETAIL